{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T18:22:17Z","timestamp":1785435737611,"version":"3.56.0"},"reference-count":34,"publisher":"Cambridge University Press (CUP)","license":[{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"unspecified","delay-in-days":165,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["cambridge.org"],"crossmark-restriction":true},"short-container-title":["Pall Supp Care"],"published-print":{"date-parts":[[2026]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"S1478951526102739_sec1a\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Patients with advanced cancer frequently experience pain and psychological distress, often requiring controlled substances such as opioids and benzodiazepines. Although access to these medications increases risk of substance misuse, little is known about how clinicians and patients discuss controlled substance use during cancer care. Understanding these conversations may inform safer prescribing, improve patient outcomes, and support management of substance use disorder (SUD) risk. We aimed to characterize discussions of controlled substance use in oncology visits, including who initiated conversations, clinician responses, and verbalized SUD risk factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S1478951526102739_sec2b\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Five coders reviewed 826 audio-recorded oncology visits from a prior clinical trial. Encounters were coded for substance type, initiator (patient, clinician, both, neither), clinician\/patient response style (avoidant, concerned\/emotional, engaged, neutral, resistant), and substance misuse risk factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S1478951526102739_sec3c\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Mean patient age was 59.5\u00a0years; most were female (55.8%), White (81.7%), and married (71.7%). Substance-related content appeared in 14.6% of counters (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a0121; 92 unique patients). Mentioned substances included opioids and sedative-hypnotics (benzodiazepines\/sleep aids), with oxycodone referenced in 67 visits. Patients initiated discussions more frequently (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a051) than clinicians (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a033), though not significantly,\n                      <jats:italic>\u03c7<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      (1,\n                      <jats:italic>N<\/jats:italic>\n                      \u00a0=\u00a095)\u00a0=\u00a033.00,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a00.078. For the remaining encounters, neither initiated (n= 24) or both initiated (n=13). Among patient-initiated discussions, clinician response types were engaged (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a025), neutral (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a010), avoidant (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a012), concerned\/emotional (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a01), or resistant (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a03). Common substance misuse risk factors included inadequate pain management (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a028), medication concerns (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a017), dose escalation (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a011), psychological concerns (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a011), and substance misuse\/drug-seeking (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S1478951526102739_sec4d\">\n                    <jats:title>Significance of results<\/jats:title>\n                    <jats:p>Despite widespread prescribing of controlled substances in oncology, discussions remain infrequent, and clinician responses to SUD-related concerns are often insufficient. These findings highlight opportunities to improve communication and risk management in cancer care.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1017\/s1478951526102739","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T12:16:07Z","timestamp":1781525767000},"update-policy":"https:\/\/doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":0,"title":["Substance use risk and controlled substances discussions in cancer care: Observations from audio-recorded patient\u2013clinician encounters"],"prefix":"10.1017","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0254-3864","authenticated-orcid":false,"given":"Miryam","family":"Yusufov","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02jzgtq86","id-type":"ROR","asserted-by":"publisher"}],"name":"Dana-Farber Cancer Institute"},{"name":"Harvard Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn I.","family":"Pollak","sequence":"additional","affiliation":[{"name":"Duke Cancer Institute"},{"name":"Duke University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanneke","family":"Poort","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02jzgtq86","id-type":"ROR","asserted-by":"publisher"}],"name":"Dana-Farber Cancer Institute"},{"name":"Harvard Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3716-6736","authenticated-orcid":false,"given":"Yvan","family":"Beaussant","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02jzgtq86","id-type":"ROR","asserted-by":"publisher"}],"name":"Dana-Farber Cancer Institute"},{"name":"Harvard Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise C.","family":"Tarbi","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02jzgtq86","id-type":"ROR","asserted-by":"publisher"}],"name":"Dana-Farber Cancer Institute"},{"name":"Harvard Medical School"},{"id":[{"id":"https:\/\/ror.org\/0155zta11","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Vermont"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard E.","family":"Leiter","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02jzgtq86","id-type":"ROR","asserted-by":"publisher"}],"name":"Dana-Farber Cancer Institute"},{"name":"Harvard Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Tulsky","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02jzgtq86","id-type":"ROR","asserted-by":"publisher"}],"name":"Dana-Farber Cancer Institute"},{"name":"Harvard Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2026,6,15]]},"reference":[{"key":"S1478951526102739_ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2021.09.011"},{"key":"S1478951526102739_ref24","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-015-2656-2"},{"key":"S1478951526102739_ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s11864-022-00954-4"},{"key":"S1478951526102739_ref6","doi-asserted-by":"publisher","DOI":"10.1200\/OP.2024.20.10_suppl.299"},{"key":"S1478951526102739_ref5","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.33639"},{"key":"S1478951526102739_ref25","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djaa122"},{"key":"S1478951526102739_ref11","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2012-0041"},{"key":"S1478951526102739_ref9","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djaa112"},{"key":"S1478951526102739_ref13","doi-asserted-by":"publisher","DOI":"10.1111\/add.14940"},{"key":"S1478951526102739_ref22","first-page":"517","article-title":"Substance abuse issues in cancer patients. Part 1: Prevalence and diagnosis","volume":"12","author":"Passik","year":"1998","journal-title":"Oncology (Williston Park, N.Y.)"},{"key":"S1478951526102739_ref21","doi-asserted-by":"publisher","DOI":"10.1177\/10499091231164634"},{"key":"S1478951526102739_ref4","doi-asserted-by":"publisher","DOI":"10.2147\/PGPM.S123376"},{"key":"S1478951526102739_ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2011.03.009"},{"key":"S1478951526102739_ref32","doi-asserted-by":"publisher","DOI":"10.1097\/HRP.0000000000000384"},{"key":"S1478951526102739_ref14","doi-asserted-by":"publisher","DOI":"10.17226\/13172"},{"key":"S1478951526102739_ref34","article-title":"Patient-related barriers to chronic pain management among cancer survivors: A narrative synthesis","author":"Zhu","year":"2025","journal-title":"Research Square"},{"key":"S1478951526102739_ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2018.10.493"},{"key":"S1478951526102739_ref8","doi-asserted-by":"publisher","DOI":"10.1177\/1049909114531445"},{"key":"S1478951526102739_ref29","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-018-0241-y"},{"key":"S1478951526102739_ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.genhosppsych.2019.04.016"},{"key":"S1478951526102739_ref27","doi-asserted-by":"publisher","DOI":"10.1007\/s11916-010-0118-6"},{"key":"S1478951526102739_ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.dadr.2024.100270"},{"key":"S1478951526102739_ref15","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2023.5785"},{"key":"S1478951526102739_ref18","doi-asserted-by":"publisher","DOI":"10.1093\/abm\/kaaa111"},{"key":"S1478951526102739_ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2017.11.042"},{"key":"S1478951526102739_ref23","unstructured":"Passik, SD and Portenoy, RK (1998). Prevalence of substance abuse disorders in cancer patients. Cancer Network."},{"key":"S1478951526102739_ref26","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2020.7612"},{"key":"S1478951526102739_ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-021-06392-4"},{"key":"S1478951526102739_ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2024.04.006"},{"key":"S1478951526102739_ref1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.30240"},{"key":"S1478951526102739_ref16","doi-asserted-by":"publisher","DOI":"10.3109\/00952990.2011.643990"},{"key":"S1478951526102739_ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.copsyc.2019.01.011"},{"key":"S1478951526102739_ref33","doi-asserted-by":"publisher","DOI":"10.1002\/1099-1611(200101\/02)10:1<19::AID-PON501>3.0.CO;2-6"},{"key":"S1478951526102739_ref17","doi-asserted-by":"publisher","DOI":"10.1080\/00952990.2019.1581793"}],"container-title":["Palliative and Supportive Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S1478951526102739","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T12:25:21Z","timestamp":1781699121000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S1478951526102739\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":34,"alternative-id":["S1478951526102739"],"URL":"https:\/\/doi.org\/10.1017\/s1478951526102739","relation":{},"ISSN":["1478-9515","1478-9523"],"issn-type":[{"value":"1478-9515","type":"print"},{"value":"1478-9523","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"\u00a9 The Author(s), 2026. Published by Cambridge University Press.","name":"copyright","label":"Copyright","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http:\/\/creativecommons.org\/licenses\/by\/4.0), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.","name":"license","label":"License","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"e173"}}